Literature DB >> 25129411

Simultaneous determination of seven bufadienolides in rat plasma after oral administration of Shexiang Baoxin Pill by liquid chromatography-electrospray ionization-tandem mass spectrometry: application to a pharmacokinetic study.

Shuping Wang1, Chengcheng Peng2, Peng Jiang3, Peng Fu4, Jianfei Tao5, Lin Han3, Huimei Huang3, Wanlin Chang3, Le Li6, Weidong Zhang7, Runhui Liu8.   

Abstract

A liquid chromatography-electrospray ionization-tandem mass spectrometry method was described for the simultaneous determination of resibufogenin, bufalin, gamabufotalin, telibufagin, arenobufagin, cinobufagin and bufotalin in rat plasma. Plasma samples were pretreated by liquid-liquid extraction with ethyl acetate. Chromatographic separation was carried out on an ACQUITY HSS T3 column with gradient elution using mobile phase consisting of acetonitrile-0.1% formic acid in water at a flow rate of 0.3 mL/min. All analytes showed good linearity over a wide concentration range (r>0.99). The lower limit of quantification was in the range of 0.5-10 ng/mL for seven bufadienolides. The mean recovery of the analytes ranged from 94.36 to 104.18%. The intra- and inter-day precisions were in the range of 1.74-13.78% and the accuracies were between 89.37 and 101.38%. The validated method was successfully applied to a pharmacokinetic (PK) study of the seven bufadienolides in rat plasma after oral administration of Shexiang Baoxin Pill (SBP). The selected PK marker compounds with typical efficacy/toxicity may provide a practical solution for marker compound selection and dosage design for the therapeutic drug monitoring and PK study of SBP in its clinical applications.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bufadienolides; LC–ESI–MS/MS; Pharmacokinetic study; Shexiang Baoxin Pill

Mesh:

Substances:

Year:  2014        PMID: 25129411     DOI: 10.1016/j.jchromb.2014.07.038

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke.

Authors:  Zong-Shi Qin; Yu Zheng; Xi-Dan Zhou; Dong-Dong Shi; Dan Cheng; Chun Shum Shek; Chang-Sen Zhan; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

2.  Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS.

Authors:  Ming Li; Yanhong Qin; Zhe Li; Jinshuai Lan; Tong Zhang; Yue Ding
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.